Insider Trading & Ownership of JOHN JOHNSON

Location: Seattle, WA
Summary: The estimated net worth of JOHN JOHNSON is at least $8,068,722 dollars as of 19 Dec 2025. JOHN JOHNSON is the Director of Xeris Biopharma Holdings, Inc. and owns shares of Xeris Biopharma Holdings, Inc. (XERS) stock worth about $5,037,227. JOHN JOHNSON is the Executive Chairman, Director of Applied Therapeutics, Inc. and owns shares of Applied Therapeutics, Inc. (APLT) stock worth about $2,915,000. JOHN JOHNSON is the Director of Verastem, Inc. and owns shares of Verastem, Inc. (VSTM) stock worth about $116,495.
Signature: /s/ Beth Hecht, Attorney-in-Fact
All Insider Reports: All Insider Reports

Notify me when JOHN JOHNSON files a new Insider Trading report.

Ownership of JOHN JOHNSON

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
XERS	Xeris Biopharma Holdings, Inc.	Director	$5,037,227	-$1,763,479	-25.9%	19 Dec 2025
APLT	Applied Therapeutics, Inc.	Executive Chairman, Director	$2,915,000			19 Dec 2024
VSTM	Verastem, Inc.	Director	$116,495			22 May 2025
AXGN	Axogen, Inc.	Director	$0	-$1,433,607	-100%	08 Dec 2025
SBBP	Strongbridge Biopharma plc	Chief Executive Officer, Director				05 Oct 2021

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.